281 related articles for article (PubMed ID: 18635422)
1. Visfatin and apelin, new adipocytokines, and their relation to endothelial function in patients with chronic renal failure.
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
Adv Med Sci; 2008; 53(1):32-6. PubMed ID: 18635422
[TBL] [Abstract][Full Text] [Related]
2. Visfatin and endothelial function in dialyzed patients.
Malyszko J; Malyszko JS; Mysliwiec M
Nephrology (Carlton); 2010 Mar; 15(2):190-6. PubMed ID: 20470278
[TBL] [Abstract][Full Text] [Related]
3. Elevated resistin is related to inflammation and residual renal function in haemodialysed patients.
Malyszko J; Malyszko JS; Kozminski P; Pawlak K; Mysliwiec M
Nephrology (Carlton); 2007 Jun; 12(3):246-53. PubMed ID: 17498119
[TBL] [Abstract][Full Text] [Related]
4. Endothelial function and novel adhesion molecule CD44 in kidney allograft recipients.
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
Transplant Proc; 2008 Dec; 40(10):3470-3. PubMed ID: 19100415
[TBL] [Abstract][Full Text] [Related]
5. Visfatin, a new adipocytokine, is predominantly related to inflammation/endothelial damage in kidney allograft recipients.
Malyszko J; Malyszko JS; Mysliwiec M
Transplant Proc; 2009; 41(1):150-3. PubMed ID: 19249500
[TBL] [Abstract][Full Text] [Related]
6. Apelin, a novel adipocytokine, in relation to endothelial function and inflammation in kidney allograft recipients.
Malyszko J; Malyszko JS; Pawlak K; Wolczynski S; Mysliwiec M
Transplant Proc; 2008 Dec; 40(10):3466-9. PubMed ID: 19100414
[TBL] [Abstract][Full Text] [Related]
7. Endothelial cell injury markers in chronic renal failure on conservative treatment and continuous ambulatory peritoneal dialysis.
Małyszko J; Małyszko JS; Myśliwiec M
Kidney Blood Press Res; 2004; 27(2):71-7. PubMed ID: 14691349
[TBL] [Abstract][Full Text] [Related]
8. Possible relations between thyroid function, endothelium, and kidney and liver function in kidney allograft recipients.
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
Transplant Proc; 2006 Dec; 38(10):3509-13. PubMed ID: 17175317
[TBL] [Abstract][Full Text] [Related]
9. Markers of endothelial cell activation/injury: CD146 and thrombomodulin are related to adiponectin in kidney allograft recipients.
Małyszko J; Małyszko JS; Brzosko S; Wołczynski S; Myśliwiec M
Am J Nephrol; 2005; 25(3):203-10. PubMed ID: 15897668
[TBL] [Abstract][Full Text] [Related]
10. Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.
Axelsson J; Witasp A; Carrero JJ; Qureshi AR; Suliman ME; Heimbürger O; Bárány P; Lindholm B; Alvestrand A; Schalling M; Nordfors L; Stenvinkel P
Am J Kidney Dis; 2007 Feb; 49(2):237-44. PubMed ID: 17261426
[TBL] [Abstract][Full Text] [Related]
11. Is there a link between CD146, a novel adhesion molecule and other markers of endothelial dysfunction in nephrotic syndrome and continuous ambulatory peritoneal dialysis?
Małyszko J; Małyszko JS; Myśliwiec M
Thromb Res; 2005; 115(1-2):19-24. PubMed ID: 15567448
[TBL] [Abstract][Full Text] [Related]
12. Serum visfatin concentration and endothelial dysfunction in chronic kidney disease.
Yilmaz MI; Saglam M; Carrero JJ; Qureshi AR; Caglar K; Eyileten T; Sonmez A; Cakir E; Yenicesu M; Lindholm B; Stenvinkel P; Axelsson J
Nephrol Dial Transplant; 2008 Mar; 23(3):959-65. PubMed ID: 17984105
[TBL] [Abstract][Full Text] [Related]
13. Resistin, a new adipokine, is related to inflammation and renal function in kidney allograft recipients.
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
Transplant Proc; 2006 Dec; 38(10):3434-6. PubMed ID: 17175295
[TBL] [Abstract][Full Text] [Related]
14. VAP-1, a novel molecule linked to endothelial damage and kidney function in kidney allograft recipients.
Koc-Zorawska E; Malyszko J; Malyszko JS; Mysliwiec M
Kidney Blood Press Res; 2012; 36(1):242-7. PubMed ID: 23154672
[TBL] [Abstract][Full Text] [Related]
15. Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation.
Cugno M; Mari D; Meroni PL; Gronda E; Vicari F; Frigerio M; Coppola R; Bottasso B; Borghi MO; Gregorini L
Br J Haematol; 2004 Jul; 126(1):85-92. PubMed ID: 15198737
[TBL] [Abstract][Full Text] [Related]
16. Thyroid function, endothelium, and inflammation in hemodialyzed patients: possible relations?
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
J Ren Nutr; 2007 Jan; 17(1):30-7. PubMed ID: 17198929
[TBL] [Abstract][Full Text] [Related]
17. Serum visfatin as a non-traditional biomarker of endothelial dysfunction in chronic kidney disease: an Egyptian study.
Bessa SS; Hamdy SM; El-Sheikh RG
Eur J Intern Med; 2010 Dec; 21(6):530-5. PubMed ID: 21111939
[TBL] [Abstract][Full Text] [Related]
18. The relationship of visfatin levels to inflammatory cytokines and left ventricular hypertrophy in hemodialysis and continuous ambulatory peritoneal dialysis patients.
Erten Y; Ebinç FA; Ebinç H; Paşaoğlu H; Demirtaş C; Taçoy G; Koç E; Derici U; Reis KA; Bali M; Arinsoy T; Sindel S
Ren Fail; 2008; 30(6):617-23. PubMed ID: 18661412
[TBL] [Abstract][Full Text] [Related]
19. Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis.
Cerinic MM; Valentini G; Sorano GG; D'Angelo S; Cuomo G; Fenu L; Generini S; Cinotti S; Morfini M; Pignone A; Guiducci S; Del Rosso A; Kalfin R; Das D; Marongiu F
Semin Arthritis Rheum; 2003 Apr; 32(5):285-95. PubMed ID: 12701039
[TBL] [Abstract][Full Text] [Related]
20. Effects of atorvastatin on apelin, visfatin (nampt), ghrelin and early carotid atherosclerosis in patients with type 2 diabetes.
Kadoglou NP; Sailer N; Kapelouzou A; Lampropoulos S; Vitta I; Kostakis A; Liapis CD
Acta Diabetol; 2012 Aug; 49(4):269-76. PubMed ID: 21748474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]